IOVANCE BIOTHERAPEUTICS, INC. Quarterly Operating Lease, Payments in USD from Q3 2018 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Iovance Biotherapeutics, Inc. quarterly/annual Operating Lease, Payments history and growth rate from Q3 2018 to Q3 2024.
  • Iovance Biotherapeutics, Inc. Operating Lease, Payments for the quarter ending September 30, 2024 was $4.5M, a 4.57% increase year-over-year.
  • Iovance Biotherapeutics, Inc. Operating Lease, Payments for the twelve months ending September 30, 2024 was $17.3M, a 3.62% increase year-over-year.
  • Iovance Biotherapeutics, Inc. annual Operating Lease, Payments for 2023 was $16.9M, a 18.7% increase from 2022.
  • Iovance Biotherapeutics, Inc. annual Operating Lease, Payments for 2022 was $14.2M, a 15.4% increase from 2021.
  • Iovance Biotherapeutics, Inc. annual Operating Lease, Payments for 2021 was $12.3M, a 47.1% increase from 2020.
Operating Lease, Payments, Trailing 12 Months (USD)
Operating Lease, Payments, Quarterly (USD)
Operating Lease, Payments, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 $4.5M +$197K +4.57% Sep 30, 2024 10-Q 2024-11-07
Q2 2024 $4.29M +$56K +1.32% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.29M +$129K +3.1% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.17M +$220K +5.57% Dec 31, 2023 10-K 2024-02-28
Q3 2023 $4.31M +$1.12M +35.1% Sep 30, 2023 10-Q 2024-11-07
Q2 2023 $4.24M +$973K +29.8% Jun 30, 2023 10-Q 2024-08-08
Q1 2023 $4.16M +$350K +9.18% Mar 31, 2023 10-Q 2024-05-09
Q4 2022 $3.95M +$215K +5.76% Dec 31, 2022 10-K 2024-02-28
Q3 2022 $3.19M -$417K -11.6% Sep 30, 2022 10-Q 2023-11-07
Q2 2022 $3.26M +$750K +29.9% Jun 30, 2022 10-Q 2023-08-08
Q1 2022 $3.81M +$1.35M +54.5% Mar 31, 2022 10-Q 2023-05-10
Q4 2021 $3.73M +$1.36M +57.1% Dec 31, 2021 10-K 2023-02-28
Q3 2021 $3.61M +$1.71M +90.4% Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $2.51M +$606K +31.8% Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $2.47M +$269K +12.2% Mar 31, 2021 10-Q 2022-05-05
Q4 2020 $2.38M -$406K -14.6% Dec 31, 2020 10-K 2022-02-24
Q3 2020 $1.89M -$570K -23.1% Sep 30, 2020 10-Q 2021-11-04
Q2 2020 $1.91M -$71K -3.59% Jun 30, 2020 10-Q 2021-08-05
Q1 2020 $2.2M +$797K +56.9% Mar 31, 2020 10-Q 2021-05-06
Q4 2019 $2.78M Dec 31, 2019 10-K 2021-02-25
Q3 2019 $2.46M +$2.4M +4075% Sep 30, 2019 10-Q 2020-11-05
Q2 2019 $1.98M Jun 30, 2019 10-Q 2020-08-06
Q1 2019 $1.4M Mar 31, 2019 10-Q 2020-05-05
Q3 2018 $59K Oct 19, 2018 10-Q 2020-11-05
* An asterisk sign (*) next to the value indicates that the value is likely invalid.